根据CPIC-CYP2C19-PPI剂量指南,在印度人口中实施药物遗传学测试,以优化质子抑制剂的使用:时代的需要
Santenna Chenchula1, Shubham Atal1, Ratinder Jhaj1
1Department of Pharmacology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.
在CYP2C19的遗传变异显著影响质子抑制剂 (PPI) 的有效性. 了解印度的CYP2C19遗传特征对于个性化PPI治疗和改善患者治疗结果至关重要.
科学领域:
- 药物基因组学 药物基因组学
- 遗传学 遗传学 是一个
- 胃肠病学 胃肠病学
背景情况:
- 质子抑制剂 (PPI) 广泛用于与酸有关的胃肠道疾病.
- CYP2C19基因变异影响PPI代谢和疗效.
- 个性化医疗方法,如CYP2C19基因定型,可以增强PPI治疗.
研究的目的:
- 审查印度人口中CYP2C19遗传分析的相关性.
- 为了突出药物基因组学 (PGx) 信息的PPI治疗的重要性.
- 检查临床药物基因组实施联盟 (CPIC) -CYP2C19-PPI指南.
主要方法:
- 对CYP2C19变体的审查 (正常,下降,损失和功能增加).
- 对CYP2C19-PPI相互作用的CPIC指南的审查.
- 分析印度的实施挑战和战略.
主要成果:
- 印度人口在CYP2C19.9中表现出显著的遗传多样性.
- 印度每个人平均携带8种临床显著的PGx变异.
- 国际指导方针为印度的PGx知情PPI使用提供了基础证据.
结论:
- 在印度,CYP2C19基因分析对于个性化PPI治疗至关重要.
- 实施基因测试需要解决基础设施,意识和政策挑战.
- 利用国际准则可以提高印度的PPI安全性和有效性.
更多相关视频
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
09:30Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
Published on: August 17, 2022
相关概念视频
Analysis of Population Pharmacokinetic Data
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Nonlinear Pharmacokinetics: Overview
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Nonlinear Pharmacokinetics: Role of Transporters
Polymorphisms occurring in drug transporters can alter...
Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
